NOS2 and asthma: Given the oxidative stress and pro-inflammatory nature of iNOS, and the beneficial role of iNOS inhibition in liver fibrosis, iNOS has been considered a potential therapeutic target for various diseases, including liver fibrosis [58,59], septic shock [60], and asthma [61].